Search MDT
Medtronic plc
NYSE · CIK 1613103
Last close86.38
Daily change-0.06 (-0.07%)
10 Years gain+27.49%
Dividends TTM2.86 (+1.42%)
Dividend yield3.31%
Fundamental Analysis
MDT · STANDARD
SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Fiscal year end 0424
Fundamental
58.9Momentum
58.1Acceleration
61.1Confidence
91.0Annual Revenue14
Quarterly Revenue58
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth11.3 / 25
Quality11.4 / 25
Capital Efficiency10.2 / 20
Balance Sheet15.0 / 15
Shareholder Economics9.0 / 10
Forward Indicators2.0 / 5
Signals
Operating leverageOperating margin improved by 1.6179 percentage points.
ROIC expansionROIC improved by 3.1431 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 0.0855%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM12.2%OK
Revenue CAGR 3Y5.21%OK
Gross Margin64.92%OK
Operating Margin17.51%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC12.04%OK
Incremental Operating Margin 3Y13.12%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-0.09%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Apr 24, 2026 | $36.36B | $23.64B | $6.47B | $7.33B | $5.43B | 65.02% | 17.78% | 14.92% | 12.14% | 1.29B |
| 2026 FY Apr 25, 2025 | $33.54B | $21.91B | $5.96B | $7.04B | $5.19B | 65.32% | 17.76% | 15.46% | 11.65% | 1.29B |
| 2026 FY Apr 26, 2024 | $32.36B | $21.15B | $5.14B | $6.79B | $5.20B | 65.34% | 15.89% | 16.07% | 9.07% | 1.33B |
| 2025 FY Apr 28, 2023 | $31.23B | $20.51B | $5.49B | $6.04B | $4.58B | 65.67% | 17.56% | 14.67% | 8.67% | 1.33B |
| 2024 FY Apr 29, 2022 | $31.69B | $21.54B | $5.75B | $7.35B | $5.98B | 67.98% | 18.15% | 18.87% | 12.22% | 1.35B |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $36.31B | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-060473, 0001628280-25-053988 |
| Revenue Growth TTM | 12.2% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-060473, 0001628280-25-053988 |
| Revenue CAGR 3Y | 5.21% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-044354 |
| Revenue CAGR 5Y | 3.84% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-044354 |
| Gross Profit CAGR 3Y | 4.86% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-044354 |
| Operating Income Growth | 23.62% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-060473, 0001628280-25-053988 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 64.92% | Gross Profit / Revenue | OK | 0001628280-26-060473, 0001628280-25-053988 |
| Operating Margin | 17.51% | Operating Income / Revenue | OK | 0001628280-26-060473, 0001628280-25-053988 |
| ROIC | 12.04% | NOPAT / Average Invested Capital | OK | 0001628280-26-060473, 0001628280-25-053988 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-060473 |
| Current Ratio | 2.07x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 3.48x | (Cash + Short-term Investments) / Total Debt | OK | 0001628280-26-060473 |
| Revenue per Diluted Share | $28.26 | Revenue / Diluted Shares | OK | 0001628280-26-060473, 0001628280-25-053988 |